Atlas Trials

Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting

Clinical trial NCT02525991 · COMPLETED

Trial details

NCT number
NCT02525991
Sponsor
Ferrer Internacional S.A.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Agitation
Start date
2016-09-08
Primary completion
2019-12-31
Enrollment
323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.